Holen Sie sich die Stockscreener-App
0.597
0.55%
-0.0033
Handel nachbörslich:
.60
0.003
+0.50%
Schlusskurs vom Vortag:
$0.6003
Offen:
$0.5992
24-Stunden-Volumen:
667.39K
Relative Volume:
0.71
Marktkapitalisierung:
$58.97M
Einnahmen:
$301.71M
Nettoeinkommen (Verlust:
$-201.99M
KGV:
-0.3118
EPS:
-1.9144
Netto-Cashflow:
$13.79M
1W Leistung:
+7.45%
1M Leistung:
+7.43%
6M Leistung:
-33.23%
1J Leistung:
-60.20%
1-Tages-Spanne:
$0.5635
$0.6274
1-Wochen-Bereich:
$0.5307
$0.6274
52-Wochen-Spanne:
$0.4511
$1.7799
Docgo Inc Stock (DCGO) Company Profile
Firmenname
Docgo Inc
Sektor
Branche
Telefon
(844) 443-6246
Adresse
685 THIRD AVENUE, NEW YORK
Compare DCGO vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DCGO
Docgo Inc
|
0.597 | 58.97M | 301.71M | -201.99M | 13.79M | -1.9144 |
HCA
Hca Healthcare Inc
|
406.59 | 90.20B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
204.25 | 17.59B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
232.80 | 14.94B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.02 | 12.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
110.16 | 10.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-08-18 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-04-19 | Eingeleitet | Deutsche Bank | Buy |
| 2022-01-19 | Eingeleitet | Stifel | Buy |
| 2021-12-21 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-12-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Docgo Inc Aktie (DCGO) Neueste Nachrichten
DCGO Q1 2026 Earnings: EPS Misses Estimates, Stock Edges HigherEPS Guidance Update - dars.gov.et
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
DocGo Extends $26 Million Share Repurchase Program - TipRanks
DocGo extends $26M share repurchase program expiration to Dec. 31, 2026 - TradingView
DocGo (NASDAQ: DCGO) extends $26M share repurchase program to year-end 2026 - Stock Titan
DCGO Q1 2026 Earnings: EPS Misses Estimates Despite Stock SurgeGuidance Upgrade Report - dars.gov.et
DCGO Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Yet Stock Rises 6.5%Annual Earnings Summary - dars.gov.et
Price to sales forward of DocGo Inc. – NASDAQ:DCGO - TradingView
Enterprise value to EBITDA forward of DocGo Inc. – NASDAQ:DCGO - TradingView
Price to book forward of DocGo Inc. – NASDAQ:DCGO - TradingView
DocGo Inc. Actuals & Estimates (NASDAQ:DCGO) - TradingView
DCGO Forecast — Price Target — Prediction for 2027 - TradingView
DocGo Inc.'s Equity Buyback Plan Extended till December 31, 2026. - marketscreener.com
DocGo Inc (DCGO) Institutional Confidence - TradingKey
DocGo Inc (DCGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DCGO Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 7.5%Financial Health Score - dars.gov.et
DocGo shareholders approve reverse stock split and board nominees at annual meeting - Investing.com UK
DocGo Shareholders Approve Reverse Split, Elect Directors - TipRanks
DocGo (NASDAQ: DCGO) holders OK reverse split and reject officer exculpation - Stock Titan
DocGo Inc (DCGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
DocGo Inc (DCGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DocGo Inc (DCGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
DocGo Inc (DCGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DocGo Inc (DCGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DocGo Inc (DCGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DocGo Inc (DCGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DCGO: Board transitions, proposal approvals, and record growth highlight a pivotal year - TradingView
DocGo (DCGO) Holds Near Support at $0.55 as Trading Volume Remains SubduedFibonacci Retracement - dars.gov.et
DocGo Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesSegment Revenue Breakdown - newsline.com
DocGo (DCGO) Goldman Sachs 47th Annual Global Healthcare Conference 2026 Summary - Quartr
DCGO: Transitioning to proactive, tech-enabled care, the company targets growth and profitability - TradingView
DocGo launches mobile phlebotomy services in southern Florida By Investing.com - Investing.com India
DocGo launches mobile phlebotomy services in southern Florida - Investing.com
DocGo Launches Mobile Phlebotomy Services in South Florida - Business Wire
At-home blood draws come to South Florida as DocGo expands - Stock Titan
DocGo Q1 2026 Earnings: EPS Misses Estimates by 36.55% as Profitability Challenges PersistBuyback Announcement Report - newsline.com
DocGo Inc. (DCGO) Edges Upward Amidst Narrow Trading RangeNegative Gamma - newsline.com
DocGo Q1 2026 Earnings: EPS Misses Estimates as Losses WidenInvestor Earnings Call - thelegaladvocate.com
DocGo (DCGO) price target decreased by 10.71% to 1.91 - MSN
DCGO|DocGo Inc|Price:0.658|Chg%:0.00 - TradingKey
DocGo targets profitability as it pivots to mobile health, medical transport - MSN
DCGODocGo Inc Stock Price and Quote - Finviz
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
DocGo Inc. (DCGO) Q1 2026 Earnings: Wider-Than-Expected Loss Pressures SharesSocial Flow Trades - Newser
DocGo Inc. (DCGO) Navigates Resistance at $0.63 as Shares Edge LowerWeak Sell Signals - thelegaladvocate.com
DocGo outlines $310M-$315M 2026 revenue outlook while targeting 75% mobile phlebotomy growth - MSN
How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets - Yahoo Finance
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport - sharewise.com
DocGo Inc.Common Stock (NQ: DCGO - The Chronicle-Journal
US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results - Sahm
Finanzdaten der Docgo Inc-Aktie (DCGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):